serw-MX  [xml]  
 


    
 Categorias DeCS

E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.760 Epidemiologic Study Characteristics .
E05.318.760.250 Clinical Studies as Topic .
E05.318.760.250.500 Clinical Trials as Topic .
E05.318.760.250.500.210 Clinical Trials, Phase II as Topic .
E05.318.760.250.500.220 Clinical Trials, Phase III as Topic .
E05.318.760.250.500.230 Clinical Trials, Phase IV as Topic .
E05.337 Evaluation Studies as Topic .
E05.337.800 Product Surveillance, Postmarketing .
E05.337.800.200 Clinical Trials, Phase IV as Topic .
E05.337.925 Validation Studies as Topic .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.335 Evaluation Studies as Topic .
N05.715.360.335.500 Validation Studies as Topic .
N05.715.360.775 Epidemiologic Study Characteristics .
N05.715.360.775.088 Clinical Studies as Topic .
N05.715.360.775.088.500 Clinical Trials as Topic .
N05.715.360.775.088.500.210 Clinical Trials, Phase II as Topic .
N05.715.360.775.088.500.220 Clinical Trials, Phase III as Topic .
N05.715.360.775.088.500.230 Clinical Trials, Phase IV as Topic .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.450 Epidemiologic Study Characteristics .
N06.850.520.450.250 Clinical Studies as Topic .
N06.850.520.450.250.250 Clinical Trials as Topic .
N06.850.520.450.250.250.210 Clinical Trials, Phase II as Topic .
N06.850.520.450.250.250.220 Clinical Trials, Phase III as Topic .
N06.850.520.450.250.250.230 Clinical Trials, Phase IV as Topic .
SP4 Environmental Health .
SP4.051 General Aspects .
SP4.051.542 Evaluation Studies as Topic .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.012 Epidemiologic Studies .
SP5.001.012.038 Analytical Epidemiology .
SP5.001.012.038.069 Validation Studies as Topic .
V03 Study Characteristics .
V03.400 Evaluation Studies .
VS2 Health Surveillance of Products .
VS2.002 Drug and Narcotic Control .
VS2.002.003 Drug Evaluation .
VS2.002.003.001 Drug Approval .
VS2.002.003.001.003 Clinical Trials as Topic .
VS2.002.003.001.003.002 Clinical Trials, Phase II as Topic .
VS2.002.003.001.003.003 Clinical Trials, Phase III as Topic .
VS2.002.003.001.003.004 Clinical Trials, Phase IV as Topic .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Evaluation Studies as Topic .
Critique .
Evaluation Indexes .
Evaluation Methodology .
Evaluation Report .
Evaluation Research .
Methodology, Evaluation .
Pre-Post Tests .
Qualitative Evaluation .
Quantitative Evaluation .
Theoretical Effectiveness .
Use-Effectiveness .
Critiques .
Effectiveness, Theoretical .
Evaluation Methodologies .
Evaluation Reports .
Evaluation, Qualitative .
Evaluation, Quantitative .
Evaluations, Qualitative .
Evaluations, Quantitative .
Indexes, Evaluation .
Methodologies, Evaluation .
Pre Post Tests .
Pre-Post Test .
Qualitative Evaluations .
Quantitative Evaluations .
Report, Evaluation .
Reports, Evaluation .
Research, Evaluation .
Test, Pre-Post .
Tests, Pre-Post .
Use Effectiveness .
Evaluation Methods .
Evaluation Techniques .
Status Report .
1.00
 
Evaluation Studies .
Evaluation Studies [Publication Type] .
0.78
 
Clinical Trials, Phase II as Topic .
Drug Evaluation, FDA Phase 2 as Topic .
Drug Evaluation, FDA Phase II as Topic .
Evaluation Studies, FDA Phase 2 as Topic .
Evaluation Studies, FDA Phase II as Topic .
Phase II Clinical Trials as Topic .
Phase II Clinical Trials .
Drug Evaluation, FDA Phase II .
Evaluation Studies, FDA Phase II .
Clinical Trials, Phase II .
0.78
 
Clinical Trials, Phase III as Topic .
Clinical Trials, Phase 3 as Topic .
Drug Evaluation, FDA Phase 3 as Topic .
Drug Evaluation, FDA Phase III as Topic .
Evaluation Studies, FDA Phase 3 as Topic .
Evaluation Studies, FDA Phase III as Topic .
Phase III Clinical Trials as Topic .
Drug Evaluation, FDA Phase III .
Evaluation Studies, FDA Phase III .
Phase III Clinical Trials .
Clinical Trials, Phase III .
0.78
 
Clinical Trials, Phase IV as Topic .
Clinical Trials, Phase 4 as Topic .
Drug Evaluation, FDA Phase 4 as Topic .
Drug Evaluation, FDA Phase IV as Topic .
Evaluation Studies, FDA Phase 4 as Topic .
Evaluation Studies, FDA Phase IV as Topic .
Drug Evaluation, FDA Phase IV as Topic .
Evaluation Studies, FDA Phase IV as Topic .
Phase IV Clinical Trials as Topic .
Phase IV Clinical Trials .
Drug Evaluation, FDA Phase IV .
Evaluation Studies, FDA Phase IV .
Clinical Trials, Phase IV .
0.77
 
Validation Studies as Topic .
0.72